Chart does not reflect overnight price.

Contract research organization ICON is set to acquire rival PRA Health Sciences in a $12 billion deal that will vault the combined company into second place among clinical trial services providers.

In recent trading, shares of ProAssurance Corp (Symbol: PRA) have crossed above the average analyst 12-month target price of $18.25, changing hands for $23.02/share. When a stock reaches the target an ...

ICON has agreed to acquire PRA Health Sciences for approximately $12 billion in cash and stock, the companies said, in a deal that continues the consolidation of contract research organizations (CROs) ...

PRA is trading near the top of its 52-week range and above its 200-day simple moving average. Price change The price of PRA shares has increased $0.05 since the market last closed. This is a 0.21% ...